Vimarsana
Biggest News Aggregation in the World

Page 2 - Per Hall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Per Hall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Per Hall Today - Breaking & Trending Today

Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Recent Accomplishments and Strategy for 2022 - Vimarsana News

Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Recent Accomplishments and Strategy for 2022

SEATTLE, Jan. 27, 2022 -- Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and...

Atossa Therapeutics Begins Enrollment of Phase 2 Clinical - Vimarsana News

Atossa Therapeutics Begins Enrollment of Phase 2 Clinical

SEATTLE, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to develop...

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting - Vimarsana News

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation. New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting iCAD, Inc.March 8, 2021 GMT Company showcased expanded ProFound AI platform, including ProFound AI Risk, the world’s first clinical decision support tool that provides a highly accurate short-term risk estimation specific to each woman NASHUA, N.H., March 08, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions,...

Source: apnews.com